Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Catherine Wu
Dana Farber Cancer Inst, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Neon Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
please see attached
Cancer Immune Monitoring and Analysis Center
Narrative There has been recent rapid expansion of immunotherapy clinical trials to treat patients with cancer as well as of the types of sophisticated tests that can be applied to patient blood and tissues collected as part of these clinical trials that promise to provide deep insights regarding why these treatments are effective. The goal of this application is to develop a specialized center with expertise in the important area of new clinical trials and in how we can learn from these trials based on the application of a battery of molecular, pathology and immunologic assays to these samples. We leverage long track record of experience in this area, having performed these types of analyses for our local studies, to now contribute to the creation of a network of similarly-oriented centers to support, harmonize, compare, and disseminate existing and new approaches for learning of the mechanisms underlying responses to immune-based therapies for the treatment of cancer.
Filed on November 06, 2017.
Tell us what you know about Catherine Wu's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Catherine Wu filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Catherine Wu | Dana Farber Cancer Inst | Conflict of Interest | Neon Therapuetics | $100,000 - $149,999 |
| Catherine Wu | Dana Farber Cancer Inst | Conflict of Interest | Neon Therapeutics | $100,000 - $149,999 |
| Catherine Wu | Dana Farber Cancer Inst | Conflict of Interest | Neon Therapuetics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.